REZA GORAVANCHI: Open Payments
NPI 1861886830 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$389 in 10 payments from 3 companies in 2025. Trend: 2023 $140 · 2024 $375 · 2025 $389
Food & beverage: $389
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $208 |
| E.R. Squibb & Sons, L.L.C. | 7 | $165 |
| Lundbeck LLC | 1 | $16 |
Products named: INGREZZA, COBENFY, REXULTI.
Industry payments across NV — which companies pay providers there.
